{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:10:40Z","timestamp":1789013440095,"version":"build-2803163510"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011094","name":"Public Health Agency of Canada","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011094","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Co-circulation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with other respiratory viruses raised concerns that coinfections may increase pediatric coronavirus disease 2019 (COVID-19) severity, but evidence is limited by variable testing practices. We assessed the epidemiology and outcomes of SARS-CoV-2 respiratory viral coinfections in hospitalized children.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We analyzed national surveillance data from the Canadian Immunization Monitoring Program, ACTive (IMPACT) COVID-19 study. Children aged &lt;17 years hospitalized with confirmed COVID-19 during Delta and Omicron periods were included. Coinfection was defined as SARS-CoV-2 plus \u22651 additional respiratory virus. Primary analyses were restricted to centres with systematic multiplex polymerase chain reaction (PCR) testing of all admissions with acute respiratory illness (n = 5), while secondary analyses included all centres (n = 13). Associations with outcomes (respiratory support, ventilation, intensive care and severe COVID-19) were estimated using multivariable mixed-effects logistic regression and adjusted odds ratios (aORs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Among 2831 hospitalized children, 938 were admitted at centers with systematic multiplex PCR testing, among whom 18.6% had \u22651 respiratory viral coinfection. Respiratory syncytial virus (39.7%) and enterovirus\/rhinovirus (38.5%) coinfections were the most common. Coinfections were not associated with increased odds of severe COVID-19 in centers with systematic multiplex PCR testing (aOR 0.94; 95% confidence interval, 0.76\u20131.15). In secondary analyses including all centers irrespective of testing strategy, coinfections were associated with increased odds of severe COVID-19 (aOR 1.42; 95% confidence interval, 1.05\u20131.91).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In centers that systematically conducted multiplex PCR testing, SARS-CoV-2 respiratory viral coinfections were not associated with increased COVID-19 severity. Differences observed when including centers without systematic testing underscore the importance of considering testing strategies when evaluating the clinical impact of coinfections.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000005396","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:02:10Z","timestamp":1789012930000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["SARS-CoV-2 Coinfections and Severity in Hospitalized Children With Systematic Testing"],"prefix":"10.1097","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3586-0612","authenticated-orcid":false,"given":"Costanza","family":"Di Chiara","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases"},{"name":"Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7823-1912","authenticated-orcid":false,"given":"Daniel S.","family":"Farrar","sequence":"additional","affiliation":[{"name":"Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2118-4174","authenticated-orcid":false,"given":"Julie A","family":"Bettinger","sequence":"additional","affiliation":[{"name":"Vaccine Evaluation Center, BC Children\u2019s Hospital Research Institute, Vancouver, British Columbia, Canada"},{"name":"Division of Infectious Diseases, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Campigotto","sequence":"additional","affiliation":[{"name":"Division of Microbiology, The Hospital for Sick Children, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1429-9341","authenticated-orcid":false,"given":"Olivier","family":"Drouin","sequence":"additional","affiliation":[{"name":"Division of General Pediatrics, Department of Pediatrics, CHU Sainte-Justine, Montreal, Quebec, Canada"},{"name":"Department of Social and Preventive Medicine, School of Public Health, Universit\u00e9 de Montr\u00e9al, Montr\u00e9al, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1967-3940","authenticated-orcid":false,"given":"Joanne","family":"Embree","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Child Health"},{"name":"Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Winnipeg, Montreal, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Halperin","sequence":"additional","affiliation":[{"name":"Canadian Center for Vaccinology, Dalhousie University and IWK Health Centre, Halifax, Nova Scotia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5716-743X","authenticated-orcid":false,"given":"Taj","family":"Jadavji","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Alberta Children\u2019s Hospital, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1564-5488","authenticated-orcid":false,"given":"Kescha","family":"Kazmi","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4232-871X","authenticated-orcid":false,"given":"Jesse","family":"Papenburg","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Diseases, Department of Pediatrics, Montreal Children\u2019s Hospital, Montreal, Quebec, Canada"},{"name":"Division of Microbiology, Department of Clinical and Laboratory Medicine, McGill University Health Centre, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5955-8098","authenticated-orcid":false,"given":"Rupeena","family":"Purewal","sequence":"additional","affiliation":[{"name":"Division of Paediatric Infectious Diseases, Jim Pattison Children\u2019s Hospital, Saskatoon, Saskatchewan, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Sadarangani","sequence":"additional","affiliation":[{"name":"Vaccine Evaluation Center, BC Children\u2019s Hospital Research Institute, Vancouver, British Columbia, Canada"},{"name":"Division of Infectious Diseases, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2341-9018","authenticated-orcid":false,"given":"Laura","family":"Sauv\u00e9","sequence":"additional","affiliation":[{"name":"Vaccine Evaluation Center, BC Children\u2019s Hospital Research Institute, Vancouver, British Columbia, Canada"},{"name":"Division of Infectious Diseases, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9981-368X","authenticated-orcid":false,"given":"Karina A.","family":"Top","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Kakkar","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, CHU Sainte-Justine, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9809-0822","authenticated-orcid":false,"given":"Shaun K.","family":"Morris","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases"},{"name":"Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada"},{"name":"Department of Pediatrics, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Division of Clinical Public Health, Centre for Vaccine Preventable Diseases, Dalla Lana School of Public Health, Toronto, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for Members of the Canadian Immunization Monitoring Program, Active (IMPACT) COVID-19 Study","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"R1-20260910","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.15585\/mmwr.mm7029a1","article-title":"Changes in influenza and other respiratory virus activity during the COVID-19 pandemic\u2014United States, 2020\u20132021.","volume":"70","author":"Olsen","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"Supplement_1","key":"R2-20260910","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1093\/cid\/ciab311","article-title":"Changes in seasonal respiratory illnesses in the United States during the coronavirus disease 2019 (COVID-19) pandemic.","volume":"73","author":"Rodgers","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R3-20260910","first-page":"100015","article-title":"The impact of the COVID-19 pandemic on influenza, respiratory syncytial virus, and other seasonal respiratory virus circulation in Canada: a population-based study.","volume":"1","author":"Groves","year":"2021","journal-title":"Lancet Reg Health Am"},{"key":"R4-20260910","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41467-021-21157-9","article-title":"Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand.","volume":"12","author":"Huang","year":"2021","journal-title":"Nat Commun"},{"key":"R5-20260910","doi-asserted-by":"crossref","first-page":"e2336863","DOI":"10.1001\/jamanetworkopen.2023.36863","article-title":"Pediatric RSV-associated hospitalizations before and during the COVID-19 pandemic.","volume":"6","author":"Bourdeau","year":"2023","journal-title":"JAMA Netw Open"},{"key":"R6-20260910","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.3390\/v15051160","article-title":"Epidemiology of respiratory infections during the COVID-19 pandemic.","volume":"15","author":"Principi","year":"2023","journal-title":"Viruses"},{"key":"R7-20260910","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/INF.0000000000004623","article-title":"Respiratory viral co-infection in SARS-CoV-2-infected children during the early and late pandemic periods.","volume":"44","author":"Xie","year":"2025","journal-title":"Pediatr Infect Dis J"},{"key":"R8-20260910","doi-asserted-by":"crossref","first-page":"e2365","DOI":"10.1002\/rmv.2365","article-title":"Respiratory viral co-infections in patients with COVID-19 and associated outcomes: a systematic review and meta-analysis.","volume":"33","author":"Krumbein","year":"2023","journal-title":"Rev Med Virol"},{"key":"R9-20260910","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12879-025-10521-5","article-title":"Co-infection of SARS-CoV-2 and influenza A\/B among patients with COVID-19: a systematic review and meta-analysis.","volume":"25","author":"Golpour","year":"2025","journal-title":"BMC Infect Dis"},{"key":"R10-20260910","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3390\/v15040865","article-title":"COVID-19 and respiratory virus co-infections: a systematic review of the literature.","volume":"15","author":"Maltezou","year":"2023","journal-title":"Viruses"},{"key":"R11-20260910","doi-asserted-by":"crossref","first-page":"05040","DOI":"10.7189\/jogh.12.05040","article-title":"The role of respiratory co-infection with influenza or respiratory syncytial virus in the clinical severity of COVID-19 patients: a systematic review and meta-analysis.","volume":"12","author":"Cong","year":"2022","journal-title":"J Glob Health"},{"key":"R12-20260910","first-page":"100337","article-title":"Risk factors for severe COVID-19 in hospitalized children in Canada: a national prospective study from March 2020\u2013May 2021.","volume":"15","author":"Farrar","year":"2022","journal-title":"Lancet Reg Health Am"},{"key":"R13-20260910","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1045-1870(03)00036-0","article-title":"Immunization monitoring program, active: a model of active surveillance of vaccine safety.","volume":"14","author":"Scheifele","year":"2003","journal-title":"Semin Pediatr Infect Dis"},{"key":"R14-20260910","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41390-025-03853-0","article-title":"Pediatric COVID-19 severity by SARS-CoV-2 lineage and vaccine status in Canada: an IMPACT study.","volume":"98","author":"Farrar","year":"2025","journal-title":"Pediatr Res"},{"key":"R15-20260910","doi-asserted-by":"crossref","first-page":"e2022059037","DOI":"10.1542\/peds.2022-059037","article-title":"Codetections of other respiratory viruses among children hospitalized with COVID-19.","volume":"151","author":"Agathis","year":"2023","journal-title":"Pediatrics"},{"key":"R16-20260910","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/INF.0000000000004856","article-title":"Severity of COVID-19 in hospitalized immunocompromised children across Canada.","volume":"44","author":"Di Chiara","year":"2025","journal-title":"Pediatr Infect Dis J"},{"key":"R18-20260910","doi-asserted-by":"crossref","first-page":"30494","DOI":"10.2807\/1560-7917.ES.2017.22.13.30494","article-title":"GISAID: global initiative on sharing all influenza data\u2014from vision to reality.","volume":"22","author":"Shu","year":"2017","journal-title":"Euro Surveill"},{"key":"R19-20260910","doi-asserted-by":"crossref","first-page":"106501","DOI":"10.1016\/j.jinf.2025.106501","article-title":"Impact of co-infection with SARS-CoV-2 and other respiratory viruses on illness: pooled analyses of 11 COVID-19 cohorts.","volume":"90","author":"de Hoog","year":"2025","journal-title":"J Infect"},{"key":"R20-20260910","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/PEC.0000000000002814","article-title":"SARS-CoV-2 with concurrent respiratory viral infection as a risk factor for a higher level of care in hospitalized pediatric patients.","volume":"38","author":"Dikranian","year":"2022","journal-title":"Pediatr Emerg Care"},{"key":"R21-20260910","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1002\/jmv.26964","article-title":"Where have all the viruses gone? Disappearance of seasonal respiratory viruses during the COVID-19 pandemic.","volume":"93","author":"Tang","year":"2021","journal-title":"J Med Virol"},{"key":"R22-20260910","doi-asserted-by":"crossref","first-page":"e0287395","DOI":"10.1371\/journal.pone.0287395","article-title":"Changes in hospitalizations and emergency department respiratory viral diagnosis trends before and during the COVID-19 pandemic in Ontario, Canada.","volume":"18","author":"Habbous","year":"2023","journal-title":"PLoS One"},{"key":"R23-20260910","doi-asserted-by":"crossref","first-page":"501","DOI":"10.14745\/ccdr.v49i1112a06","article-title":"Syndromic surveillance performance in Canada throughout the COVID-19 pandemic, March 1, 2020 to March 4, 2023.","volume":"49","author":"Ben Moussa","year":"2023","journal-title":"Can Commun Dis Rep"},{"key":"R24-20260910","doi-asserted-by":"crossref","first-page":"e0242302","DOI":"10.1371\/journal.pone.0242302","article-title":"Systematic review and meta-analysis of the prevalence of common respiratory viruses in children <2 years with bronchiolitis in the pre-COVID-19 pandemic era.","volume":"15","author":"Kenmoe","year":"2020","journal-title":"PLoS One"},{"key":"R25-20260910","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/INF.0000000000004560","article-title":"Impact of respiratory syncytial virus and severe acute respiratory syndrome coronavirus 2 coinfection on clinical severity and outcomes among children hospitalized with lower respiratory tract infections in Soweto, South Africa.","volume":"44","author":"Mrubata","year":"2025","journal-title":"Pediatr Infect Dis J"},{"key":"R26-20260910","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jiac.2019.07.014","article-title":"The impact analysis of a multiplex PCR respiratory panel for hospitalized pediatric respiratory infections in Japan.","volume":"26","author":"Kitano","year":"2020","journal-title":"J Infect Chemother"},{"key":"R27-20260910","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.2169\/internalmedicine.8021-21","article-title":"Frequency and significance of coinfection in patients with COVID-19 at hospital admission.","volume":"60","author":"Ishiguro","year":"2021","journal-title":"Intern Med"},{"key":"R28-20260910","doi-asserted-by":"crossref","first-page":"106474","DOI":"10.1016\/j.jinf.2025.106474","article-title":"Co-infection dynamics of SARS-CoV-2 and respiratory viruses in the 2022\/2023 respiratory season in the Netherlands.","volume":"90","author":"Carstens","year":"2025","journal-title":"J Infect"},{"key":"R29-20260910","doi-asserted-by":"crossref","first-page":"e20210583","DOI":"10.1084\/jem.20210583","article-title":"Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics.","volume":"218","author":"Cheemarla","year":"2021","journal-title":"J Exp Med"},{"key":"R30-20260910","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/infdis\/jiab147","article-title":"Human rhinovirus infection blocks severe acute respiratory syndrome coronavirus 2 replication within the respiratory epithelium: implications for COVID-19 epidemiology.","volume":"224","author":"Dee","year":"2021","journal-title":"J Infect Dis"},{"key":"R31-20260910","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1002\/jmv.26098","article-title":"SARS-CoV-2 coinfections: could influenza and the common cold be beneficial?","volume":"92","author":"Pinky","year":"2020","journal-title":"J Med Virol"},{"key":"R32-20260910","doi-asserted-by":"crossref","first-page":"e0251170","DOI":"10.1371\/journal.pone.0251170","article-title":"Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: a systematic review and meta-analysis.","volume":"16","author":"Musuuza","year":"2021","journal-title":"PLoS One"},{"key":"R33-20260910","doi-asserted-by":"crossref","first-page":"1127401","DOI":"10.3389\/fimmu.2023.1127401","article-title":"Comparison of the mucosal and systemic antibody responses in Covid-19 recovered patients with one dose of mRNA vaccine and unexposed subjects with three doses of mRNA vaccines.","volume":"14","author":"Liu","year":"2023","journal-title":"Front Immunol"},{"key":"R34-20260910","doi-asserted-by":"crossref","first-page":"1181121","DOI":"10.3389\/fimmu.2023.1181121","article-title":"Breakthrough infection evokes the nasopharyngeal innate immune responses established by SARS-CoV-2-inactivated vaccine.","volume":"14","author":"He","year":"2023","journal-title":"Front Immunol"},{"key":"R35-20260910","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41590-024-02052-z","article-title":"Variants and vaccines impact nasal immunity over three waves of SARS-CoV-2.","volume":"26","author":"Walsh","year":"2025","journal-title":"Nat Immunol"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005396","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:02:14Z","timestamp":1789012934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":34,"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000005396","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]}}}